Skip to content
CNCB News
International News Portal 17 November 2026 Headlines from established publishers
Business

I founded a cancer biotech company. Then, my mom, dad, and I were all diagnosed with cancer.

Dr. Ryan Beal is the CEO of Dyve, a cancer-biotech company. He, his dad, and his mom have all had cancer.

the source while receiving treatment
Dr. Ryan Beal founded a cancer-focused biotech company. Then, he got cancer himself.
  • Dr. Ryan Beal founded a bioscience company focused on cancer treatment in 2014.
  • Years later, he was diagnosed with a rare cancer, and his approach to the business shifted.
  • Being in the oncologist's office helped him understand the human impact of his innovations.

This as-told-to essay is based on a conversation with Dr. Ryan Beal, CEO of Dyve Biosciences. It has been edited for length and clarity.

My brother and I were about 60 miles into a 120-mile race in Colorado when chest pain made me stop. I thought I was having a cardiac emergency, but doctors diagnosed me with thymoma — a rare cancer of the thymus gland, which sits in the middle of the chest.

To say it was a shock is an understatement. I was only 49 and healthy enough to run for six days through the Rockies. Months earlier, my mother had died of cancer; her celebration of life was just days before the race. My brother and I had considered canceling, but decided to run together to reflect on her life.

Instead, I found myself in an emergency room in Vail, facing a terrible diagnosis. But I had something few cancer patients do: I'm the CEO of a cancer-focused biotech company. I immediately sent my results to three doctor friends, and they got to work.

the source with his mother on a river
His mom survived breast cancer, then received a pancreatic cancer diagnosis.

I'm an MD, but went into business, rather than medicine

I've always been a science nerd, and grew up wanting to be a physician. While I was in medical school at UPenn, I developed an interest in business. Med school felt like a lot of memorization and regurgitation of facts; in business classes, there were no rote answers, but more nuance and decision-making.

Then, while assisting with a surgery, I overheard two well-respected surgeons saying they wouldn't want their kids going into medicine. That stuck with me.

I got my MD, but rather than doing a residency, I started working for McKinsey, the large consulting firm. I left that position because I wanted more time with my kids. I had another startup initially, and co-founded Dyve in 2014. Our technology delivers therapeutic agents through the skin in a noninvasive way, to target the acidic environment that cancer tumors thrive in.

the source and his brother
He and his brother ran an ultramarathon together, during which he was experiencing chest pains that led to his own diagnosis.

I didn't fully understand the emotional side until I was a patient

As I led Dyve, I was very much a scientist, focused on solving scientific problems. I knew our work would impact real people, but I very much came at the work through an empirical lens.

That changed when my mom was diagnosed with cancer. She survived breast cancer, but eight years later, was diagnosed with pancreatic cancer that killed her within weeks. Then, I was diagnosed.

I had sat in boardrooms discussing cancer infusions many, many times. Yet, I'd never sat in an infusion center or the waiting room at the oncologist's office. Being in these spaces as a patient was incredibly emotional. It was eye-opening about not only the reality of cancer, but also the work I was doing.

I'm entirely focused on patients now

In some ways, my expertise helped me through treatment. I was familiar with the chemotherapy drugs I was taking, for example. I thought navigating insurance would be easy, given my background, but it was a nightmare, even for someone who knows the system well.

I took a two-year sabbatical during treatment. It took me that long to feel like I was back to myself. My team was kind enough to say they didn't notice my brain fog, but I did.

When I returned, the way I thought about my company had dramatically shifted. Now, I'm entirely focused on the patient experience. I understand more acutely that long trials and timelines mean less hope for patients who have been told they have no more options to explore. I'm driven by emotion and my own experience now, more than science.

It takes capital to drive innovation, and I want to build a successful business where investors do well. But what drives me is patient outcomes. I want people like me, my mom, and my dad — who died of cancer more recently — to have access to better treatments. Even if that's all that happens with my business, I would be thrilled.

Read the original article on Business Insider

This story was first published by Business Insider. Read the original report